NVO vs. NBIS
NVO (Novo Nordisk A/S) and NBIS (Nebius Group N.V.) are both stocks. NVO operates in Drug Manufacturers - General (Healthcare), while NBIS operates in Internet Content & Information (Communication Services). Over the past year, NVO returned -19.26% vs 245.94% for NBIS. At a 0.14 correlation, their price movements are largely independent.
Performance
NVO vs. NBIS - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, NVO achieves a 0.91% return, which is significantly lower than NBIS's 118.17% return.
NVO
- 1D
- -1.41%
- 1M
- 14.86%
- 6M
- -17.63%
- YTD
- 0.91%
- 1Y
- -19.26%
- 3Y*
- -13.51%
- 5Y*
- 4.43%
- 10Y*
- 8.18%
- ALL TIME*
- 14.52%
NBIS
- 1D
- 2.76%
- 1M
- -36.30%
- 6M
- 67.96%
- YTD
- 118.17%
- 1Y
- 245.94%
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
- ALL TIME*
- 264.48%
NVO vs. NBIS - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | |
|---|---|---|---|
NVO Novo Nordisk A/S | 0.91% | -39.22% | -27.24% |
NBIS Nebius Group N.V. | 118.17% | 202.18% | 46.25% |
Correlation
The correlation between NVO and NBIS is 0.16, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.16 |
Correlation (All Time) Calculated using the full available price history since Oct 18, 2024 | 0.14 |
Fundamentals
NVO:
$220.46B
NBIS:
$43.83B
NVO:
DKK 27.42
NBIS:
$3.08
NVO:
11.83
NBIS:
59.23
NVO:
0.51
NBIS:
20.35
NVO:
4.40
NBIS:
56.43
NVO:
7.11
NBIS:
7.79
NVO:
DKK 327.80B
NBIS:
$877.90M
NVO:
DKK 268.30B
NBIS:
$420.60M
NVO:
DKK 181.54B
NBIS:
-$52.78M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
NVO vs. NBIS — Risk / Return Rank
NVO
NBIS
NVO vs. NBIS - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Novo Nordisk A/S (NVO) and Nebius Group N.V. (NBIS). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| NVO | NBIS | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -2.70 | ||
| Sortino ratioReturn per unit of downside risk | -3.19 | ||
| Omega ratioGain probability vs. loss probability | 0.97 | 1.34 | -0.37 |
| Calmar ratioReturn relative to maximum drawdown | -0.39 | 5.45 | -5.84 |
| Martin ratioReturn relative to average drawdown | -0.61 | 11.87 | -12.48 |
Loading charts...
Drawdowns
NVO vs. NBIS - Drawdown Comparison
The maximum NVO drawdown since its inception was -74.70%, which is greater than NBIS's maximum drawdown of -58.27%. Use the drawdown chart below to compare losses from any high point for NVO and NBIS.
Loading charts...
Drawdown Indicators
| NVO | NBIS | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -74.70% | -58.27% | -16.43% |
Max Drawdown (1Y)Largest decline over 1 year | -49.17% | -45.47% | -3.70% |
Max Drawdown (3Y)Largest decline over 3 years | -74.70% | — | — |
Max Drawdown (5Y)Largest decline over 5 years | -74.70% | — | — |
Max Drawdown (10Y)Largest decline over 10 years | -74.70% | — | — |
Current DrawdownCurrent decline from peak | -63.95% | -36.30% | -27.65% |
Average DrawdownAverage peak-to-trough decline | -17.89% | -18.90% | +1.01% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 31.75% | 20.83% | +10.92% |
Volatility
NVO vs. NBIS - Volatility Comparison
The current volatility for Novo Nordisk A/S (NVO) is 9.48%, while Nebius Group N.V. (NBIS) has a volatility of 32.60%. This indicates that NVO experiences smaller price fluctuations and is considered to be less risky than NBIS based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| NVO | NBIS | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 9.48% | 32.60% | -23.12% |
Volatility (6M)Calculated over the trailing 6-month period | 37.43% | 75.89% | -38.46% |
Volatility (1Y)Calculated over the trailing 1-year period | 51.79% | 106.91% | -55.12% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 38.58% | 110.41% | -71.83% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 32.63% | 110.41% | -77.78% |
Dividends
NVO vs. NBIS - Dividend Comparison
NVO's dividend yield for the trailing twelve months is around 3.63%, while NBIS has not paid dividends to shareholders.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
NBIS Nebius Group N.V. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
NVO Novo Nordisk A/S | 3.63% | 3.31% | 1.68% | 1.00% | 1.20% | 1.35% | 1.87% | 2.14% | 1.45% | 1.52% | 2.87% | 0.92% |
Financials
NVO vs. NBIS - Financials Comparison
This section allows you to compare key financial metrics between Novo Nordisk A/S and Nebius Group N.V.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
NVO and NBIS have a correlation of 0.16, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
NBIS has higher volatility (32.60%) compared to NVO (9.48%). In terms of maximum drawdown, NVO dropped -74.70% vs NBIS's -58.27%.
NBIS currently has the higher Sharpe Ratio (2.32 vs -0.37), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for NVO and NBIS
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer